EMR200136_593: A Study Assessing the U.S. Post-Marketing Safety Profile of Rebif® in comparison with its U.S. Prescribing Information

21/08/2014
30/03/2026
EU PAS number:
EUPAS7290
Study
Finalised
Documents
Study protocol
No information provided.
Study results
No information provided.
Study report
No information provided.
ENCePP Seal
No information provided.